06.18.25 -- Milestone Payments: Potential Trouble In The Last Mile?

While many companies maintain "pipeline" pages aimed at scientists and investors, these can overlook the needs of patients. Examine the complexities surrounding patient access to treatment options.

Genentech will invest $700 million in a new 700,000-square-foot facility in Holly Springs, NC, to create 420 jobs and boost the region’s life sciences and biomanufacturing sector.

Research presented at AMCP 2025 uses natural language processing on decision-maker feedback to predict coverage. Learn about the surprising findings and next steps in this Q&A.

Learn the history behind the Harley Jacobsen Act (H.R. 7418), a bill introduced to Congress in 2024 that seeks to exempt all clinical trial payments from taxation.

In the dynamic landscape of the life sciences industry, Medical Affairs (MA) teams and accessible digital platforms are pivotal in navigating the complexities of medical publication planning.

As U.S. biotech investment continues to rise, cross-border collaboration and trial design innovations are expected to further solidify Australia’s role in the early-stage biotech development pipeline.

When it comes to furthering AAV's potential in the wider biopharmaceutical pipeline, partnering with a CDMO that can foment an optimal analytical and manufacturing strategy is crucial.